Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Apr 15, 2010
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the first quarter ended March 31, 2010...
-
Mar 18, 2010
Company's CRT-Ds recommended for asymptomatic and mild heart failure patients
-
Mar 16, 2010
Trials to evaluate small vessel and long lesion versions of platinum chromium PROMUS® Element™ Stent System
-
Mar 15, 2010
Boston Scientific applies to FDA for expanded indications for TAXUS Express and TAXUS® Liberte® Stents in AMI patients
-
Mar 15, 2010
Analysis of the data presented at the American College of Cardiology Annual Scientific Sessions
-
Mar 15, 2010
Manufacturing process changes were not submitted for FDA approval; no indication that changes pose any risk to patient safety
-
Mar 11, 2010
First and only premounted, balloon-expandable stent approved specifically for use in iliac arteries
-
Mar 10, 2010
Clinical data presentations to include 12-month results for third-generation TAXUS® Element™ drug-eluting stent
-
Feb 23, 2010
A webcast of the March 2 session will be available. Learn how to tune in live or watch the replay
-
Feb 10, 2010
Article reported a case summary of a patient who had been implanted subcutaneously with a Cognis cardiac resynchronization therapy defibrillator